Maxim Group Initiates Coverage On Imunon with Buy Rating, Announces Price Target of $10
Benzinga Newsdesk 6 months ago
NewsPrice TargetInitiationAnalyst Ratings
Maxim Group analyst Jason McCarthy initiates coverage on Imunon (NASDAQ:IMNN) with a Buy rating and announces Price Target of $10.
Maxim Group analyst Jason McCarthy initiates coverage on Imunon (NASDAQ:IMNN) with a Buy rating and announces Price Target of $10.